// App-Quantinova.ai

588 : Inhibition of liver inflammation and tumorigenesis by blocking Ccl2-Ccr2 axis in a mouse model

Researchers

Presenter

  • Kun-Yu Teng

Principal Investigators

  • N/A

Medical Centers

  • The Ohio State Univerisity, Columbus, OH

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

  • Solid malignancies

Biomarkers

  • C-C Motif Chemokine Ligand 2

  • Natural Killer cells

  • cMYC

  • Interferon-gamma

  • Interleukin 6

  • microRNA-122

Drug/Treatment

  • IFN-lambda

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved